The IRS treats prescribed compounded medicines as Section 213(d) qualified expenses when they are medical care, but some HRA plans now explicitly exclude compounded GLP-1s, and FSA and HSA administrators may require additional substantiation
In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg
If cancer is very sensitive to the damaging effects of free radicals, then it might be possible to develop drugs that target cancer cells specifically and prevent them from producing antioxidants or that ramp up free radical levels inside of the malignant cells, exploiting their newly discovered weakness.
This has a strong scent that kinda sticks for a while, so be careful about using any extra or competing fragrance